The EU Response to the Presence of Nitrosamine Impurities in Medicines

The unexpected detection of nitrosamine impurities in human medicines has recently seen global regulators act to understand the risks of these contaminations to patients and to limit their presence. Over 300 nitrosamines are known, many of which are highly potent mutagenic carcinogens. Regulators fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruepp, Robin, Frötschl, Roland, Bream, Robert, Filancia, Maria, Girard, Thomas, Spinei, Andrei, Weise, Martina, Whomsley, Rhys
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641785/
https://www.ncbi.nlm.nih.gov/pubmed/34869504
http://dx.doi.org/10.3389/fmed.2021.782536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641785/
https://www.ncbi.nlm.nih.gov/pubmed/34869504
http://dx.doi.org/10.3389/fmed.2021.782536

Ejemplares similares